Maisel et al., reported that CD163+ TAMs in immediate proximity to cancer cells and the average number of CD163+ TAMs, either adjacent to or at communicating distance with cancer cells, were independent factors of poor clinical outcomes in BC (29). The gene discussed is CD163; the disease is cancer.